Inhibition of NO synthesis abrogated the benefits of endogenous IL-6 and IL-10 in non-steatotic and steatotic grafts, respectively, consequently increasing hepatic IL-1β and cAMP, and exacerbating inflammation and damage, more than BD did by itself in LT. This evidence concerns the gene IL1B and Behcet disease.